CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
ClōSYS® Unflavored Rinse +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03160560
NCT03160560N/ACompleted

Efficacy of ClōSYS® Oral Rinse Products in Human Subjects in Controlling Oral Malodor

Rowpar Pharmaceuticals, Inc.·interventional·Posted May 19, 2017·Updated Jan 7, 2021

In Brief

A clinical study evaluating ClōSYS® Unflavored Rinse, ClōSYS® Flavored Rinse, and 1 other intervention for Oral Malodor. Completed, enrolled 100 participants.

Detailed Summary

The purpose of this Study is to assess the efficacy of two ClōSYS Oral Rinse products in human subjects in controlling oral malodor in partial fulfillment of the requirements for American Dental Association's (ADA) requirement for obtaining ADA Seal for malodor.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOral Malodor
Countries--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 19, 2017
Enrollment StartAug 1, 2016
Primary CompletionNov 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.1 years ago

Interventions

ClōSYS® Unflavored Rinsedrug

Subjects in Test group will receive ClōSYS® Unflavored Rinse.

ClōSYS® Flavored Rinsedrug

Subjects in Test group will receive ClōSYS® Flavored Rinse.

Placeboother

Subjects in Placebo group will receive Placebo Rinse.